The Piper Super Cub was first certified in 1949, powered at the time by a Continental C90-12F. Over time, the power was increased and the final production run at Piper saw the installation of the ...

Piper Sandler raised the firm’s price target on Blueprint Medicines (BPMC) to $119 from $109 and keeps an Overweight rating on the shares ahead of earnings. With biotech having largely ...

Blueprint Medicines (NASDAQ:BPMC – Free Report) had its price objective boosted by Piper Sandler from $109.00 to $119.00 in a research note published on Monday morning,Benzinga reports.